0

Diabetes Collection
 61-80 of 110 Articles
ACP Journal Club |  17 August 2010
HbA1c levels ≤ 5.5% ruled out, and levels ≥ 7.0% ruled in, type 2 diabetes in clinical and community populations
Leonard Reeves, MD, FAAFP
Ann Intern Med. 2010;153(4):JC2-11. doi:10.7326/0003-4819-153-4-201008170-02011
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  20 July 2010
Fenofibrate plus simvastatin did not prevent major CV events more than simvastatin alone in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-5. doi:10.7326/0003-4819-153-2-201007200-02005
ACP Journal Club |  20 July 2010
Review: Metformin does not increase risk for lactic acidosis in type 2 diabetes
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2010;153(2):JC1-9. doi:10.7326/0003-4819-153-2-201007200-02009
ACP Journal Club |  20 July 2010
Higher “normal” glycated hemoglobin levels were associated with increased risk for diabetes, CVD, stroke, and mortality in adults
Steven A. Smith, MD
Ann Intern Med. 2010;153(2):JC1-13. doi:10.7326/0003-4819-153-2-201007200-02013
ACP Journal Club |  15 June 2010
Review: Statin use increases risk for diabetes
John-Michael Gamble, BScPharm, MSc; Sumit R. Majumdar, MD, MPH
Ann Intern Med. 2010;152(12):JC6-7. doi:10.7326/0003-4819-152-12-201006150-02007
ACP Journal Club |  15 June 2010
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-9. doi:10.7326/0003-4819-152-12-201006150-02009
ACP Journal Club |  15 June 2010
Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-10. doi:10.7326/0003-4819-152-12-201006150-02010
ACP Journal Club |  18 May 2010
Intensive insulin therapy did not reduce mortality more than conventional therapy in septic shock treated with corticosteroids
Katherine J. Deans, MD; Peter C. Minneci, MD
Ann Intern Med. 2010;152(10):JC5-5. doi:10.7326/0003-4819-152-10-201005180-02005
ACP Journal Club |  20 April 2010
Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-2. doi:10.7326/0003-4819-152-8-201004200-02002
ACP Journal Club |  20 April 2010
Review: Current evidence shows no overall benefit of aspirin for primary prevention of cardiovascular disease in diabetes
Michael LeFevre, MD, MSPH
Ann Intern Med. 2010;152(8):JC4-10. doi:10.7326/0003-4819-152-8-201004200-02010
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
ACP Journal Club |  19 January 2010
A lifestyle intervention improved obstructive sleep apnea more than support and education in obese patients with diabetes
Tim Reynolds, MD
Ann Intern Med. 2010;152(2):JC1-5. doi:10.7326/0003-4819-152-2-201001190-02005
ACP Journal Club |  19 January 2010
Treatment of mild gestational diabetes did not prevent neonatal complications but reduced fetal overgrowth
Denice Feig, MD
Ann Intern Med. 2010;152(2):JC1-6. doi:10.7326/0003-4819-152-2-201001190-02006
ACP Journal Club |  15 December 2009
A Mediterranean-style diet reduced need for glucose-lowering drugs more than a low-fat diet in type 2 diabetes
Andrew Mente, PhD; Sonia S. Anand, MD, PhD, FRCPC
Ann Intern Med. 2009;151(12):JC6-5. doi:10.7326/0003-4819-151-12-200912150-02005
ACP Journal Club |  15 December 2009
Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
Julio Hajdenberg, MD, FACP
Ann Intern Med. 2009;151(12):JC6-14. doi:10.7326/0003-4819-151-12-200912150-02014
ACP Journal Club |  17 November 2009
Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes
Bradley Ng, MBChB, FRANZCP
Ann Intern Med. 2009;151(10):JC5-12. doi:10.7326/0003-4819-151-10-200911170-02012
ACP Journal Club |  20 October 2009
Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD
Paul Poirier, MD, PhD, FRCPC, FACC, FAHA
Ann Intern Med. 2009;151(8):JC4-5. doi:10.7326/0003-4819-151-8-200910200-02005
ACP Journal Club |  20 October 2009
Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes
Sean F. Dinneen, MD; M. Conall Dennedy, MD; Kalpana Muthusamy, MD; et al.
Ann Intern Med. 2009;151(8):JC4-6. doi:10.7326/0003-4819-151-8-200910200-02006
ACP Journal Club |  20 October 2009
Rosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes
Lorraine L. Lipscombe, MD, MSc
Ann Intern Med. 2009;151(8):JC4-8. doi:10.7326/0003-4819-151-8-200910200-02008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)